Renal & Electrolytes

In the emergency department in the small hours, a young woman presents with a moon face, striae, blood pressure one-sixty over one-ten, and a potassium of only two point eight. The resident's first impulse is to draw a cortisol level right away; the attending stops him, explaining that cortisol follows a diurnal rhythm and a single random draw tells you nothing at all. The adrenal gland has three layers from outside in: the outer zona glomerulosa secretes aldosterone, the middle zona fasciculata secretes cortisol, and the inner zona reticularis secretes androgen, plus the catecholamines of the central medulla. The mnemonic is salt, sugar, sex — but the real essence is this sentence: the middle two layers are governed by adrenocorticotropic hormone, while the outermost salt layer belongs to the renin-angiotensin-aldosterone system. So in secondary adrenal insufficiency, what is missing is cortisol and androgen — aldosterone is barely affected, and there is no hyperkalemia or hyponatremia.

The diagnostic logic of Cushing syndrome peels back like an onion, and it goes in three steps. First confirm that excess truly exists, because cortisol follows a diurnal rhythm, high in the morning and low at night, so a single random draw means nothing at all — all three screening tools exist purely to get around that rhythm. The first is the overnight one-milligram dexamethasone suppression test: in a normal person, morning cortisol is suppressed below one point eight. The second is the twenty-four-hour urinary free cortisol, which integrates an entire day's secretion into one number. The third is late-night salivary cortisol, which catches the rhythm that should be low but is not. Once excess is confirmed, the second step tests ACTH dependence: a level that is high or normal points to a problem upstream driving adrenal hyperplasia, while a level below five to ten points to the adrenal gland secreting on its own, or to exogenous steroid on board. Only the third step localizes the source — ACTH-dependent cases still need a high-dose suppression test, pituitary MRI, or inferior petrosal sinus sampling; a pituitary adenoma retains partial feedback and is suppressed by the high dose, while ectopic ACTH, as in small-cell lung cancer, is not suppressed. The trap this entire workflow loves most is a patient who looks exactly like Cushing clinically, yet whose ACTH comes back low, whose cortisol comes back low, and whose urinary free cortisol is low as well. This is not a contradiction — it is exogenous, iatrogenic Cushing syndrome, because what the patient is taking is a synthetic steroid: it suppresses ACTH and produces the moon face and central obesity, but because the synthetic steroid is not picked up by the cortisol assay, every number falls right along with it. One line captures the rule: looks like Cushing, every test is low, it has to be a drug.

The moon-faced patient turns out, in the end, not to have Cushing syndrome at all — her true diagnosis is primary aldosteronism, the most common endocrine cause of secondary hypertension, far more common than pheochromocytoma, and the exam loves to blur these two causes together. Its tetrad falls straight out of one causal chain: the zona glomerulosa autonomously secretes a flood of aldosterone, which acts on the epithelial sodium channel of collecting-duct principal cells, retaining sodium and wasting potassium and hydrogen ion, so potassium is low, bicarbonate rises, and metabolic alkalosis follows. Sodium retention drags water along with it, expanding blood volume and suppressing renin, so renin is low. The screening test of choice is an elevated aldosterone-to-renin ratio; confirmation follows with a saline-infusion or captopril challenge test; and finally adrenal vein sampling distinguishes a unilateral adenoma, which should be operated on, from bilateral hyperplasia, which is treated with a lifelong aldosterone antagonist. The key discriminator is the direction of renin: primary disease is the adrenal gland secreting on its own and suppressing renin, while secondary disease, as in renal artery stenosis, is the kidney mistaking itself for ischemic, driving renin up, which then drives aldosterone up — both conditions have high aldosterone, but renin runs in opposite directions.

Congenital adrenal hyperplasia looks at first like rote memorization of three enzymes, but understanding one causal chain unlocks the whole topic. The cortisol synthesis pathway is like a pipeline, and the enzymes are valves along the way; when one valve gets blocked, downstream cortisol simply cannot be made, negative feedback vanishes, ACTH climbs relentlessly and drives adrenal hyperplasia, while at the same time the substrate upstream, with nowhere else to go, detours and piles up down the androgen branch. So the hyperplasia is not a tumor — it is the compensatory result of ACTH shouting nonstop. Only two things remain to work out: whether this enzyme's downstream pathway still connects to aldosterone, which decides whether salt is lost, and whether this enzyme's upstream pathway piles up into androgen, which decides whether virilization occurs. Twenty-one-hydroxylase deficiency accounts for more than ninety percent of cases: cortisol is low, aldosterone is low and can cause a salt-wasting crisis, androgen is high and virilizes female infants, blood pressure is low, and the marker is seventeen-hydroxyprogesterone piling up upstream. Eleven-hydroxylase deficiency retains salt and so causes hypertension plus virilization; seventeen-hydroxylase deficiency causes a disorder of sexual development plus hypertension without virilization. The rule need not be memorized by brute force: only twenty-one and eleven cause virilization, and only eleven and seventeen cause hypertension.

For a patient on long-term glucocorticoids, there is one direction that is most often flipped on exams, and that is serum calcium. Intuition says steroids erode bone, so calcium released from bone should cause hypercalcemia — but the truth is the opposite. Steroids simultaneously inhibit intestinal calcium absorption and promote renal calcium excretion, and together these tip the balance toward hypocalcemia; hypocalcemia then stimulates the parathyroid gland, causing secondary hyperparathyroidism and worsening bone loss. So chronic steroid use produces hypocalcemia plus elevated parathyroid hormone plus bone loss, not hypercalcemia. Another iron rule is that long-term use must never be stopped abruptly, because the hypothalamic-pituitary-adrenal axis has long since been suppressed and the adrenal glands have already atrophied — abrupt discontinuation precipitates an adrenal crisis.

Both adrenal emergencies demand management too urgent to wait for lab results. The iron rule for adrenal crisis is immediate intravenous hydrocortisone plus aggressive normal saline, without waiting for the ACTH and cortisol reports; the cause is almost always abrupt steroid withdrawal, inadequate adrenal reserve under septic stress, or bilateral adrenal hemorrhage from meningococcal Waterhouse-Friderichsen syndrome. What must be remembered about pheochromocytoma is not the clinical presentation but the order of testing and preoperative medication. The test of choice for diagnosis is not catecholamines measured directly but metanephrines instead, because catecholamines have a short half-life and are secreted in bursts, so a sample may well miss the peak, while the metabolized methoxy products remain persistently stable with a long half-life, undisturbed by paroxysmal fluctuation — so plasma free or twenty-four-hour urinary metanephrines are the gold standard. The order of preoperative medication is likewise dictated by mechanism: catecholamines simultaneously activate alpha-mediated vasoconstriction and beta-mediated tachycardia plus vasodilation, and under normal conditions the two hold each other in check; if beta is blocked first, the vasculature is left with pure alpha-mediated constriction and no beta to counter it, and blood pressure spikes instantly into a crisis. So the sequence is alpha-blockade first, plus volume expansion over several days to restore blood volume to normal, and only then the beta-blocker — that way, the instant the tumor is resected and the catecholamine supply is cut off, the patient does not crash into shock instead. The classic rule of tens remains a commonly tested mnemonic, though with the spread of genetic testing the true hereditary fraction runs closer to thirty to forty percent, linking to von Hippel-Lindau disease, multiple endocrine neoplasia type 2, and neurofibromatosis. The whole chapter strings together on just one chain: work out the two axes of ACTH and the renin-angiotensin-aldosterone system first, and the symptoms, the tests, and the order of medications all follow in turn.

In this volume the kidney plays two roles at once: the glomerulus, responsible for filtering, and the renal tubule, responsible for reabsorption and secretion. The glomerulus filters one hundred and eighty liters of plasma every day, running on the formula that net filtration pressure equals capillary hydrostatic pressure minus Bowman's-space pressure minus plasma colloid osmotic pressure. When a stone lodges in the ureter, Bowman's-space pressure is pushed up, net filtration pressure drops immediately, and glomerular filtration rate falls right along with it — this is the direct result of a pressure balance, not the body slowly adjusting through some reflex. Afferent arteriolar dilation or efferent arteriolar constriction raises the pressure inside the capillary and filtration rate rises, and this is exactly where low-dose angiotensin II and its inhibitors pull in opposite directions. When plasma protein concentration rises, the colloid osmotic pressure grows larger and pulls water back into the vessel, and filtration rate falls. One concept the exam easily flips is that ultrafiltration is the job of the glomerular capillary, while the renal tubule handles reabsorption and secretion — don't pin ultrafiltration on the renal tubule.

The test points along the renal tubule look scattered, but it takes only pinning down each segment's signature transporter. The proximal tubule reabsorbs glucose, amino acids, bicarbonate, and most of the sodium and water; glucose enters through the apical sodium-glucose cotransporter 2 and exits through the basolateral glucose transporter 2, and what drives sodium out across the basolateral membrane is the sodium-potassium ATPase, not the sodium-potassium-chloride cotransporter that belongs only to the thick ascending limb of the loop of Henle. That cotransporter, sitting on the apical membrane of the thick ascending limb, is the site of action of furosemide, and this segment is water-impermeable, which is why it dilutes the urine. The sodium chloride cotransporter of the distal tubule is the site of action of the thiazide class, and the principal cells of the collecting duct reabsorb sodium through the aldosterone-regulated epithelial sodium channel and water through the ADH-regulated aquaporin-2. Two high-frequency traps must be nailed down: glucose is reabsorbed only in the proximal tubule, since there is no sodium-glucose cotransporter downstream and no glucose reabsorption there, so once the proximal tubule is saturated, glucose leaks straight into the urine; and what drives sodium across the proximal basolateral membrane is the sodium-potassium ATPase, not the sodium-potassium-chloride cotransporter that belongs only to the thick ascending limb. The power source behind every secondary active transport process in the body is the basolateral sodium-potassium ATPase — it props up the electrochemical gradient, and only then do the apical membrane's cotransporters and antiporters have anything to work with.

The high osmotic gradient of the renal medulla is propped up by two things: the thick ascending limb of the loop of Henle actively pumping sodium chloride into the medullary interstitium, plus urea recycling in the inner medullary collecting duct. Together the two build a high osmotic pressure that gives water a reason to be drawn out and concentrate the urine. So in someone on a chronic low-protein diet, the liver makes less urea, medullary urea concentration falls, the osmotic gradient weakens, and urine-concentrating ability actually falls rather than rising — this is the item intuition most easily gets backward. The role of antidiuretic hormone is to move the channel onto the membrane: it binds the type-2 receptor on collecting-duct principal cells, triggers cyclic AMP and protein kinase A, and shuttles aquaporin-2 from intracellular vesicles onto the apical membrane, and only then can water passively follow the medulla's high osmotic gradient inward. The movement of water is passive, not active transport; aquaporin-1 sits constitutively on the membrane of the proximal tubule and the descending limb and is not under the control of antidiuretic hormone — aquaporin-2 is the one dynamically regulated by antidiuretic hormone. Two more integrative points: in the aldosterone escape of primary aldosteronism, atrial natriuretic peptide release and enhanced pressure natriuresis within one to two weeks let urinary sodium rebound, so this group of patients does not develop severe edema, yet blood pressure remains high and hypokalemia persists — escape resolves only the sodium problem, not the potassium problem; and in diabetic ketoacidosis, the kidney, in order to conserve base, reabsorbs almost all of its filtered bicarbonate, so urinary bicarbonate does not increase — instead the kidney excretes ammonium and titratable acid, together with deep, rapid Kussmaul breathing as respiratory compensation.

The mineral and bone disorder of chronic kidney disease is the story of the kidney failing at its job as an endocrine organ, and it follows one reasoning chain: glomerular filtration rate falls, phosphate can no longer be excreted, so phosphate is high — this is the first trap, since the direction is high, not low; at the same time renal 1α-hydroxylase activity falls, active vitamin D can no longer be made, intestinal calcium absorption falls, so calcium is low, and phosphate also binds calcium, dragging free calcium down further. High phosphate plus low calcium plus low active vitamin D, together with fibroblast growth factor 23, which rises early, all stimulate the parathyroid gland, producing secondary hyperparathyroidism; chronically elevated parathyroid hormone accelerates bone resorption, and cystic lucencies and brown tumors appear in bone — this is called osteitis fibrosa cystica. If parathyroid hormone is suppressed too hard, bone loses its capacity to remodel and instead becomes adynamic bone disease — neither extreme is good. Treatment follows the mechanism and is easy to grasp: a phosphate-restricted diet, plus a non-calcium phosphate binder such as sevelamer or lanthanum carbonate as first choice to avoid vascular calcification, an active vitamin D analog such as calcitriol, and the calcimimetic cinacalcet to control parathyroid hormone.

Two easy points in pediatric urology. Hypospadias questions really test only three principles: preserve the urethral plate, because it is the foundation for reconstructing the urethra; correct the chordee, or the penis remains curved after surgery; and preserve the foreskin, because a dorsal rotational flap is a commonly used reconstructive material. If staged repair or salvage surgery is needed, at least about six months must be allowed for tissue blood supply to recover — not three months, and this number is the one most often flipped on exams. Duplex ureters test only the one Weigert-Meyer rule: the upper-pole ureter inserts more inferiorly and medially and is prone to forming a ureterocele, while the lower-pole ureter inserts more superiorly and laterally and is often complicated by vesicoureteral reflux — the mnemonic is that the upper segment goes down-and-in and is prone to a ureterocele, while the lower segment goes up-and-out and is prone to reflux. Trap questions love to swap the insertion positions of the two.

Last is the neurogenic bladder. Urination is a tug-of-war between two nerves: storage runs on the sympathetic system, with β3 relaxing the detrusor and α1 closing the bladder neck, while the somatic pudendal nerve controls voluntary holding; voiding runs on the parasympathetic system, with muscarinic M3 driving detrusor contraction. So the drug logic follows in one line: anticholinergics and β3 agonists treat the storage problem of an overactive bladder, while an α-blocker relaxes the bladder neck to treat outlet obstruction. Of the detrusor's muscarinic receptors, M2 is the most abundant at about eighty percent and works through a pathway that inhibits cyclic AMP — it maintains and assists; M3, though fewer in number, works through Gq, inositol trisphosphate, and rising calcium, and is the true driving force behind contraction, so anticholinergic drugs mainly oppose M3. Reasoning downward from the site of injury, spinal cord injury below the pons and above the sacral cord loses cerebral inhibition, producing detrusor overactivity plus detrusor-sphincter dyssynergia, with high pressure, residual urine, and damage to the upper urinary tract; peripheral and below-sacral lesions, along with diabetic neuropathy, damage the autonomic and sensory fibers, producing detrusor underactivity and impaired sensation. One trap must be nailed down: urinary stones cause obstruction, not detrusor underactivity, and this is frequently used as a "does not belong to this category" distractor. The core of diabetic cystopathy is not overactivity but impaired sensation and residual urine. The final life-saving number is the pediatric neurogenic bladder's storage pressure of forty — this pressure transmits backward up the ureter, causing vesicoureteral reflux and hydronephrosis, and the management goal is to lower storage pressure, maintaining low pressure, large capacity, and complete emptying through clean intermittent catheterization plus an anticholinergic; pressure is more dangerous than volume.

The test points of urology scatter across four corners — tumor, stone, emergency, infection — but grasp each organ's signature signal, PSA for the prostate, fat density for the kidney, blood flow for the scrotum, crystals for the urine, and the branch points surface on their own. Start with benign prostatic hyperplasia. Its obstruction is built from two components: hyperplasia of the gland itself, and the smooth-muscle tone of the bladder neck and prostate. Glandular hyperplasia is driven by dihydrotestosterone, converted from testosterone by 5α-reductase, so blocking this enzyme with finasteride or dutasteride slowly shrinks the gland — but it takes time, so onset requires three to six months, and it is only significant in men whose gland exceeds forty milliliters. One commonly tested detail is that a 5α-reductase inhibitor cuts PSA by roughly half, so tracking for cancer requires correcting by a factor of two, or a true cancer will be missed. Smooth-muscle tone is caused by contraction through α1A receptors, which make up about seventy percent of prostatic α1 receptors, so α1A-selective α-blockers such as tamsulosin and silodosin act fast, working within days to weeks, regardless of gland size. The α1D receptor sits mainly in the bladder detrusor and spinal cord and is not tamsulosin's main target — the exam commonly plants this switcheroo.

A rising PSA is often misread as meaning cancer, but it is organ-specific, not cancer-specific — inflammation, infection, a digital rectal exam, cycling, ejaculation, and hyperplasia can all push it up. So on finding an elevated PSA, the next step depends on the scenario. If the elevation comes with heavy urinary leukocytes, prostatitis or infection is the culprit and inflammation is causing a false elevation in PSA — treat with antibiotics first, retest once the inflammation clears, and don't rush straight to biopsy. If the elevation comes with a free-PSA ratio below fifteen percent plus a hypoechoic lesion on ultrasound, all three clues point to cancer, and the next step is a transrectal-ultrasound- or MRI-guided biopsy. PSA's sensitivity for lymph-node metastasis is below forty percent, so staging relies on pelvic CT or MRI to check the nodes and a bone scan to find the osteoblastic bone metastases prostate cancer favors. The prostate size estimated on digital exam has no clear positive correlation with the severity of lower urinary tract symptoms — a larger gland doesn't necessarily mean worse symptoms. Erectile dysfunction after radical prostatectomy comes from intraoperative injury to the cavernous nerves within the neurovascular bundle running along the posterolateral prostate, arising from the pelvic autonomic plexus and carrying the parasympathetic signal — so a nerve-sparing technique is exactly about preserving this bundle.

For the tumor map, just seeing one image or one marker and tracing the mechanism to the right disease wins half the battle. Renal cell carcinoma is most commonly the clear-cell type, linked to the von Hippel-Lindau gene, with smoking as a risk factor; it is called the internist's tumor because its paraneoplastic syndromes are so numerous, and the most commonly tested is Stauffer syndrome, in which renal cell carcinoma secretes IL-6 and granulocyte-macrophage colony-stimulating factor, producing abnormal liver function without any liver metastasis, reversible after nephrectomy. Advanced disease is treated with VEGF or tyrosine kinase inhibitors, whose most common side effect is hypertension rather than hypothyroidism, the latter being a commonly planted distractor. Renal angiomyolipoma is benign; seeing fat density of negative ten to negative one hundred on CT confirms it, it is linked to tuberous sclerosis, and it is treated only above four centimeters. Urothelial carcinoma of the renal pelvis or ureter should come to mind the moment a filling defect is seen, and it is linked to smoking, analgesics, and aristolochic acid. Bladder cancer is most commonly urothelial carcinoma, not adenocarcinoma; its most important risk factor is smoking; Schistosoma instead points to squamous cell carcinoma; and it presents as painless hematuria. One commonly swapped direction is that among tumors metastasizing to the bladder, melanoma is the most common — if a question asks about metastasis to the bladder rather than a primary bladder tumor, choose melanoma. For testicular germ cell tumors, the key branch point is seminoma versus non-seminoma: seminoma is radiosensitive and never raises alpha-fetoprotein; non-seminoma responds poorly to radiation, does raise alpha-fetoprotein, and is treated with bleomycin, etoposide, and cisplatin chemotherapy — seeing an elevated alpha-fetoprotein rules out pure seminoma. One last conceptual trap: cryptorchidism is a risk factor for testicular cancer, but orchidopexy itself does not lower the cancer incidence — it only helps examination, fertility, and prevents torsion.

The core of stone disease always lies along the physicochemical axis of supersaturation. The promoters are calcium, oxalate, uric acid, cystine, magnesium ammonium phosphate, and matrix; the inhibitors are citrate and magnesium — citrate chelates calcium and lowers free calcium, while magnesium binds oxalate and blocks crystallization — so low urinary citrate is a risk factor, and treating magnesium or citrate as a promoter is exactly the pitfall. Calcium-containing stones make up seventy to eighty percent, with hypercalciuria the most common cause, and hyperuricosuria, hyperoxaluria, and hypocitraturia also contributing. One number commonly flipped on exams is that only about ten to fifteen percent of urinary oxalate comes from the diet, with the remaining eighty-five to ninety percent from endogenous hepatic metabolism, so dietary restriction alone has limited effect on lowering urinary oxalate — though avoiding spinach, nuts, and chocolate is still advised, paired with calcium so the gut binds oxalate and reduces its absorption. The diagnostic test of choice is non-contrast CT, because nearly every stone, including radiolucent uric acid stones and faintly radiopaque cystine stones, appears dense on CT, giving the highest sensitivity and specificity while also measuring size, location, and whether hydronephrosis is present; a plain abdominal film cannot see radiolucent uric acid stones and shows faintly radiopaque cystine stones poorly, and ultrasound, with no radiation, is preferred for pregnant women and children. The radiolucent stones are uric acid, while cystine is only faintly radiopaque; alkalinizing the urine to a pH of six point five can dissolve uric acid stones; struvite is linked to urease-producing bacteria such as Proteus, alkaline urine, and a staghorn shape, requiring complete removal by percutaneous nephrolithotomy plus antibiotics.

Acute management branches three ways. A stone with fever, sepsis, or obstruction of a solitary kidney is an emergency of obstruction complicated by infection, requiring immediate emergency decompression plus antibiotics, never going straight to lithotripsy, because breaking up the stone forces bacteria into the kidney and bloodstream and worsens the bacteremia. A stone under five to six millimeters with no infection usually passes on its own, with pain control preferring a nonsteroidal anti-inflammatory drug plus an α-blocker to help the stone pass; a larger stone or pain that can't be controlled calls for elective stone removal. Special populations follow three iron rules: pregnant women's ureteral stones are managed conservatively, with drainage, when needed, through a double-J stent or percutaneous nephrostomy, since extracorporeal shock wave lithotripsy is contraindicated in pregnancy; patients on anticoagulants or antiplatelet agents get flexible ureteroscopic lithotripsy first, since it carries the lowest bleeding risk; and the contraindications to shock wave lithotripsy are uncorrected coagulopathy, an aneurysm near the stone, severe skeletal deformity, pregnancy, and uncontrolled infection — but obesity is not a contraindication, since it only affects targeting: it's hard to aim, not impossible to treat.

The first iron rule of a scrotal emergency is to rule out testicular torsion first: once the spermatic cord twists and arterial flow is cut off, detorsion within six hours carries a high salvage rate, while beyond twenty-four hours the testis is usually necrotic. The discriminator comes down to one line: elevation makes it worse and flow is gone — that's torsion, operate immediately and don't wait for further workup, and fix the contralateral side too; epididymitis, by contrast, is relieved by elevation, shows increased flow, and is treated with antibiotics. Epididymitis pathogens branch by age: in the young and sexually active it's chlamydia and gonorrhea, not diabetes; diabetes-associated infection occurs mostly in older patients, with E. coli and other enteric organisms as the pathogens. The pairings of the testicular endocrine axis must be nailed down: Leydig cells are stimulated by luteinizing hormone to synthesize testosterone, while Sertoli cells are stimulated by follicle-stimulating hormone to support spermatogenesis and secrete inhibin — the exam loves to reverse these two pairings. The fructose in semen comes from the seminal vesicles, not the prostate. Corporal venous leakage is a vascular and structural problem of the penis, with no direct causal link to low testosterone. Phosphodiesterase type 5 inhibitors make sense the moment you trace the mechanism of erection: nitric oxide raises cyclic GMP, relaxing cavernosal smooth muscle and producing engorgement; the enzyme breaks down cyclic GMP, so inhibiting it sustains the erection — what it inhibits is type 5, not the type 6 found in the retina, where mild cross-inhibition causes blue-tinted vision. The absolute contraindication is nitrates, since combined use causes severe hypotension; rifampin is not a contraindication, merely a strong inducer that metabolizes the drug away and weakens its effect while remaining safe. Finally, a palpable undescended testis needs no MRI localization, while for a non-palpable one, laparoscopic exploration is the standard; a negative exam plus a negative ultrasound still cannot rule in anorchia, since the testis may lie deep within the abdomen. Orchidopexy, completed at roughly six to eighteen months, lowers the risk of infertility and malignant transformation, but the procedure itself does not lower the cancer incidence — it only helps examination, fertility, and prevents torsion.

Four unlabeled slides sit side by side on the pathology bench, and when the intern asks how to tell them apart at a glance, the attending smiles and says it isn't rote-memorized pairing — it's going back to where they came from. The real shortcut for recognizing the histology of the endocrine and urinary systems is going back to embryonic origin. The anterior pituitary is a pure endocrine gland, developing upward from Rathke's pouch with no duct at all, delivering hormones straight into the blood through sinusoidal capillaries alone, so a question stating that the anterior pituitary has an intercalated duct should be rejected outright, because an intercalated duct belongs to exocrine glands such as the salivary glands. The thyroid is the only gland that stores its hormone in follicles and colloid, with the colloid itself being thyroglobulin. The endocrine portion of the pancreas is called the islets of Langerhans, islands embedded in a sea of acinar tissue. The adrenal gland is a concentric structure of three cortical bands — glomerulosa, fasciculata, reticularis — around an inner medullary core. None of these patterns need to be memorized by brute force; they are simply what a shared ancestor naturally grows into once you slice through it.

The most beautiful thing about the adrenal gland is that it is really two organs stacked on top of each other. The medulla arises from the neural crest, sharing its origin with postganglionic sympathetic neurons, so the medulla's chromaffin cells are essentially specialized sympathetic neurons that grow no axon and instead dump their secretion into the blood; precisely because it is neural tissue, it takes direct cholinergic stimulation from preganglionic sympathetic fibers, making it the only endocrine tissue triggered directly by a nerve, and its main secretion is epinephrine at about eighty percent, often wrongly answered as mainly norepinephrine. The cortex, by contrast, arises from mesoderm and runs entirely on humoral signals: the zona glomerulosa answers to angiotensin II and potassium and makes aldosterone; the zona fasciculata answers to ACTH and makes cortisol; the zona reticularis likewise answers to ACTH and makes DHEA. One organ, two bosses — which is exactly why the exam loves to ask what stimulates the medulla, and the answer is always the preganglionic sympathetic nerve, never ACTH.

For the specialization of nephron epithelium, remember one location that is commonly swapped out: the macula densa belongs to the initial segment of the distal tubule, not the straight or convoluted proximal tubule, and this is exactly where the exam plants a false answer. Its job is to sense the sodium-salt concentration in the tubular lumen; when salt is high it releases adenosine to constrict the afferent arteriole and push glomerular filtration rate down, and this is tubuloglomerular feedback. Renin, by contrast, is secreted by the cluster of JG cells beside the afferent arteriole, not by the macula densa itself — don't blend these two roles together. The eyeball wall, from outside in, forms three concentric layers of fibrous, vascular, and neural tissue; the iris belongs to the middle, vascular layer, and filing the iris under the fibrous layer is a common distractor. The ciliary muscle is smooth muscle, innervated by the parasympathetic oculomotor nerve; when it contracts, the zonular fibers relax, the lens thickens, and near vision comes into focus — treating it as skeletal muscle is another commonly hit landmine.

The aristolochic acid family is the one most worth understanding by mechanism. Once aristolochic acid enters the body it forms aristolactam-DNA adducts, leaving a characteristic A-to-T transversion mutation on TP53, so the consequences split two ways: on one side the tubulointerstitium is slowly fibrosed and the kidney shrivels into a small mass, and on the other the same mutation grows cancer out of the urothelium of the upper urinary tract — this is the signature triad in this group of patients: rapidly progressive renal failure plus disproportionately severe anemia plus urothelial carcinoma of the upper urinary tract. Balkan endemic nephropathy is aristolochic acid exposure from the soil and water, Chinese herbal nephropathy is exposure from herbal medicine containing Aristolochia such as Mu Tong, and the mechanism is the same in both; karyomegalic interstitial nephritis is not caused by aristolochic acid, but it follows its own DNA-damage-linked path through a FAN1 gene deficiency that impairs DNA repair. Mesoamerican nephropathy is the exam's favorite reverse question — it is linked to heat, dehydration, repeated heat stress, and pesticides, and has not, to date, been established as linked to DNA damage, so the answer to which of the four is least like DNA damage is Mesoamerican nephropathy. Reason it out from the mechanism; there is no need to memorize it by rote.

The test point of ADPKD with intracranial aneurysm is likewise one causal chain. The polycystin made by a PKD1 or PKD2 mutation has as its main job maintaining epithelial polarity, but as a side effect it weakens the structural strength of vascular smooth muscle and collagen, so these patients are especially prone to berry aneurysms in the anterior circulation of the circle of Willis, at a prevalence of roughly five to ten percent, markedly higher than the two to three percent of the general population; the sex column hides a trap — it is women who predominate, not men, and a question stating that prevalence is higher in men is simply a false statement. When there is a family history of intracranial aneurysm or subarachnoid hemorrhage, a high-risk occupation, or a major operation planned, MRA screening is advised; rupture presents as subarachnoid hemorrhage, one of the important causes of death in ADPKD.

Last comes kidney development. During metanephric development, the ureteric bud extends outward and induces the metanephric mesenchyme to condense into a pretubular aggregate, which then undergoes mesenchymal-to-epithelial transition to grow into renal tubules and connect up into nephrons — this direction is MET, not EMT, and remembering it backward is simply wrong. The key genes for building the house, meaning making renal tubules, are Wnt4, Emx2, and Fgf8, with Wnt4 as the foreman driving MET; laying pipes alongside the house is a different crew's job, with VEGF-A and Kdr carrying the angiogenesis signal, which does not show up at the pretubular aggregation stage — so when asked which one does not participate in this stage, the answer is VEGF-A or Kdr. One line closes the whole chapter: structure determines behavior, and structure is determined by embryonic origin — remember where each piece of tissue comes from, and the pairings will grow naturally in your mind.

At four in the morning, a septic man is admitted; his creatinine jumps from 0.9 to 2.3 in a single day, and his urine output for the entire day falls short of 300 mL. AKI staging runs on two axes — how fast the kidney is falling and how much urine is coming out — with a threshold of a creatinine rise of 0.3 within 48 hours, or a rise to 1.5 times baseline within 7 days. The stage everyone reverses is stage 3: beyond a creatinine rise to 3 times baseline or above 4, or urine output too low for too long, starting dialysis alone places the patient in stage 3 outright, regardless of the creatinine at that moment. The mechanism of ATN itself is a clean chain: ischemia or a toxin drives tubular epithelial cells into apoptosis and necrosis, the sloughed cellular debris obstructs the tubular lumen, rising luminal pressure produces backleak plus obstruction, and the effective filtration rate falls. Prerenal disease means the tubules are intact but underperfused, hoarding sodium desperately, so the fractional excretion of sodium is under 1%; acute tubular necrosis means the tubules are broken, the fractional excretion of sodium is over 2%, and the urine shows muddy brown granular casts. When chronic kidney disease is complicated by AKI, a fractional excretion of sodium over 1% cannot rule out a prerenal cause, because the tubules already have impaired baseline function — switching to a fractional excretion of urea under 35% is more accurate. Diuresis after relief of obstruction appears only after relief of bilateral complete obstruction or complete obstruction of a solitary functioning kidney; when only one side is blocked and the other kidney is normal, that kidney has already compensated.

Resuscitate with isotonic crystalloids; HES worsens tubular injury and is off-limits. Severe AKI is a high-catabolic state and needs adequate protein at 1.2 to 2.5 grams per kilogram per day; a low-protein diet is a CKD strategy, and transplanting it onto AKI only starves the patient. The mnemonic for emergent dialysis, AEIOU, stands for refractory acidosis, refractory hyperkalemia, a dialyzable intoxication, refractory volume overload, and uremic symptoms; a hyperkalemic, acidotic form of AKI calls for dialysis or CRRT, while plasmapheresis clears large molecules and is useless against small molecules like potassium and acid, making it the least suitable choice. Drug-induced acute interstitial nephritis presents with mild proteinuria plus sterile pyuria plus white cell casts, and a PPI should never cause proteinuria at the nephrotic-syndrome scale. Aristolochic acid nephropathy presents with rapid renal failure, disproportionate anemia, and urothelial cancer. The timeline of contrast-induced nephropathy is a rise at 24 to 48 hours, a peak at 3 to 5 days, and recovery in 1 to 2 weeks — a vignette claiming the peak arrives at 10 to 14 days is wrong, and multiple myeloma marks the high-risk group. Nearly every complication of CKD traces back to the kidney's failure to excrete phosphate and the resulting phosphate retention. Osteocytes secrete FGF-23 to kick the phosphate back out, which is why it is the earliest mineral-metabolism marker to rise in CKD, ahead of both PTH and serum phosphate. It promotes phosphate excretion, suppresses the synthesis of active vitamin D, and, via Klotho, suppresses PTH — so early on it can hold PTH down briefly. But as renal function keeps falling, Klotho falls too, that suppressive line breaks, and PTH runs out of control from then on; relentless hypocalcemic stimulation of the parathyroid glands then drives secondary hyperparathyroidism, with calcium low or normal and phosphate high. After prolonged secondary stimulation the glands turn autonomous, and calcium flips high — that is tertiary hyperparathyroidism. FGF-23 is trying to suppress PTH, not stimulate it — never reverse that direction.

CKD anemia is treated by replacing the building blocks of erythropoiesis first and giving EPO afterward; stage 4 with proteinuria calls for a low-protein diet plus a single ACEi or ARB, with NSAIDs forbidden and combining the two forbidden. For renal replacement therapy, transplant survival beats peritoneal dialysis, which runs about even with hemodialysis, and HD has the worst 5-year survival. Fungal peritonitis requires immediate catheter removal plus systemic antifungals. The fastest rescue for uremic bleeding is DDAVP; the side effects of androgens are hepatotoxicity and virilization, not thrombosis. NSF is linked to linear gadolinium, but HD can clear gadolinium, so dialysis should follow immediately whenever it must be used. Sirolimus causes hyperlipidemia and proteinuria, tacrolimus causes new-onset diabetes after transplant, and cyclosporine is the one that causes hyperuricemia — pinning hyperuricemia onto sirolimus is a frequent exam mistake. The first cut in glomerular disease separates nephritic from nephrotic; the second cut looks at complement. Post-streptococcal glomerulonephritis appears 1 to 3 weeks after the infection, with low complement and IgG plus C3 humps; lupus shows a full-house pattern with both C3 and C4 low; IgA nephropathy has normal complement, mesangial IgA, and runs almost simultaneously with the infection at 1 to 3 days — that timing gap is the fastest way to split it from post-streptococcal glomerulonephritis. Anti-glomerular basement membrane disease is linear IgG against the α3-NC1 domain of type IV collagen, while α5 belongs to Alport syndrome with sensorineural hearing loss. ANCA-associated disease is pauci-immune with crescents. Rapidly progressive glomerulonephritis is treated across the board with steroids plus cyclophosphamide; for ANCA, rituximab is now ranked equal to, or even ahead of, cyclophosphamide, and anti-GBM disease or severe presentations add plasmapheresis. Membranous nephropathy carries the highest thrombotic risk among the nephrotic syndromes, with renal vein thrombosis in 30 to 40 percent, because anticoagulant proteins are lost in the urine while the liver compensates by raising clotting factors. The dipstick tests only for albumin, not for light chains, so suspected myeloma calls for serum immunoelectrophoresis. Chronic tubulointerstitial disease presents with slowly progressive renal failure plus normochromic normocytic anemia while iron studies remain normal. C4d deposition means antibody-mediated rejection, treated with plasmapheresis plus IVIg plus rituximab; basiliximab, raising the CNI dose, and pulse steroids are all least appropriate for antibody-mediated rejection. The logic behind renal vascular disease and tumors is just as clean. Hyaline arteriolosclerosis comes from aging, hypertension, and diabetes; pheochromocytoma causes paroxysmal hypertension dominated by fibrinoid necrosis, so hyaline thickening is the least likely finding. FMD shows a string-of-beads pattern, with the media most common but the intima and adventitia both possible — confining it to the media is wrong. Drug-induced acute interstitial nephritis is a type IV delayed hypersensitivity reaction with an infiltrate dominated by T lymphocytes and macrophages, not eosinophils. The hallmark of analgesic nephropathy is papillary necrosis, accompanied by urinary tract infection in about half of cases rather than over 90 percent. XGP shows foamy macrophages plus a staghorn calculus plus obstruction, most commonly caused by Proteus because it produces urease and alkalinizes the urine. Diabetic nephropathy shows Kimmelstiel-Wilson nodules plus mesangial sclerosis plus basement membrane thickening but no immune deposits; idiopathic FSGS is a podocytopathy classified as primary kidney disease and does not belong to diabetes. Renal cell carcinoma favors spread along the vein, traveling from the renal vein to the vena cava to the right atrium to form a tumor thrombus, making the renal artery the least likely site for tumor; among the paraneoplastic syndromes, a rise in erythropoietin causes polycythemia — the exact opposite of the anemia seen in most cancers — and a rise in PTHrP causing hypercalcemia is a frequent test point.

Three patients arrive in the emergency department at once. The first has been vomiting for three days — pH 7.52, HCO₃⁻ 38, potassium 2.9, urine chloride 12 — a chloride-responsive metabolic alkalosis: the loss of gastric acid raises the HCO₃⁻, volume depletion drives the kidney to reabsorb NaCl aggressively so urine chloride falls below 20, and rising aldosterone washes out potassium; treatment is isotonic saline plus KCl, and at this point the urine osmolality is high rather than low, and the plasma osmolality is not low. The second patient has pH 7.30, HCO₃⁻ 16, pCO2 32, and an AG of 20; Winter's prediction of 1.5 times 16 plus 8 equals exactly 32, so this is a pure high-AG metabolic acidosis. The third patient, with a history of SLE, seized, with sodium at 115 and a urine osmolality of 250 — exactly what SIADH should look like: euvolemia plus a urine osmolality above 100 plus a urine sodium above 20 plus low BUN and uric acid.

The four steps of acid-base interpretation are the pH, identifying the primary disorder, calculating the Winter's compensation, and, for a metabolic acidosis, always calculating the AG. Winter's predicted pCO2 equals 1.5 times the HCO₃⁻ plus 8; an exact match means a pure disorder, while too little or too much compensation means a second primary disorder is present. Metformin accumulation driving lactate buildup is a favorite high-AG scenario, distinguished from DKA by glucose rising only mildly with no ketones. Salicylate is the classic mixed disorder: it directly stimulates the respiratory center to cause a respiratory alkalosis, while also uncoupling oxidative phosphorylation and letting lactate and ketoacids accumulate to cause a high-AG acidosis — a pCO2 below the Winter's prediction is the telltale clue. A delta ratio of about 1 to 2 is a pure high-AG process; below 1 means a coexisting normal-AG acidosis; above 2 means a coexisting metabolic alkalosis. The main causes of a normal-AG acidosis are diarrhea and RTA, split using the UAG: in diarrhea the UAG turns negative, while in RTA it is positive. Type I RTA has a failure of distal hydrogen secretion, hypokalemia, a urine pH that is always above 5.5, and the strongest tendency to form calcium phosphate stones; type II RTA has impaired proximal HCO₃⁻ reabsorption and often accompanies Fanconi syndrome; type IV RTA is aldosterone deficiency or resistance, the only one with hyperkalemia, and diabetic nephropathy is its most common cause. The principal cells of the collecting duct are under aldosterone control, so potassium-sparing diuretics and aldosterone antagonists both act on the principal cells rather than the intercalated cells; type A intercalated cells secrete hydrogen — A stands for Acid.

The three steps of hyponatremia begin with the plasma osmolality: a hypertonic reading is the pseudo-direction produced by hyperglycemia or mannitol, an isotonic reading is the pseudohyponatremia of hyperlipidemia or hyperproteinemia, and only a hypotonic reading is true hyponatremia. The second step checks the volume status: hypovolemic looks like vomiting, diarrhea, or diuretics; euvolemic looks like SIADH, hypothyroidism, adrenal insufficiency, or primary polydipsia; hypervolemic looks like heart failure, cirrhosis, or nephrotic syndrome. The third step checks the urine osmolality: below 100 is water diuresis, above 100 means ADH is still acting. The causal chain of SIADH itself is that excess ADH keeps the collecting-duct water channel inserted in the membrane, water reabsorption increases, dilution of the body fluids produces euvolemic hyponatremia plus concentrated urine, and volume expansion suppresses the RAAS while dilution makes the urine sodium paradoxically high, with BUN and uric acid both low. In hypervolemic hyponatremia from heart failure, the urine sodium is below 20, because activation of the RAAS and the sympathetic nervous system retains sodium relentlessly. The speed of correction is a matter of life and death: 3 percent saline is reserved for severe symptoms or extreme hyponatremia; correcting faster than 8 to 10 per day causes osmotic demyelination syndrome, also known as central pontine myelinolysis; chronic hyponatremia must be corrected slowly. Polyuria is read from the urine osmolality: below 300 is water diuresis, pointing to diabetes insipidus or primary polydipsia; above 300 is solute diuresis, pointing to hyperglycemia, contrast agents, or high-protein feeding; a value of 450 means solute diuresis, not diabetes insipidus. A DDAVP test response above 50 percent is central, and DDAVP is the treatment; no response is nephrogenic, commonly from lithium, hypercalcemia, or hypokalemia. Hypokalemia plus hypertension is read from the direction of renin and aldosterone: primary hyperaldosteronism, Conn syndrome, has low renin and high aldosterone; a secondary cause such as renal artery stenosis raises both; Liddle syndrome and Cushing syndrome or licorice ingestion lower both. The causal chain of Liddle syndrome itself is that a mutation keeps the epithelial sodium channel constitutively active, the principal cells of the collecting duct reabsorb sodium and excrete potassium relentlessly, and so the result is hypertension plus hypokalemia plus alkalosis plus both renin and aldosterone low. Renin rising while aldosterone falls is a physiological contradiction and the least likely answer, because the RAAS by its nature requires the two to move together. Hypokalemia is split using the urine potassium: normal or low means a shift, as in periodic paralysis, TPP, alkalosis, insulin, and β-agonists; above 20 means renal loss, as in diuretics, Bartter syndrome, Gitelman syndrome, hyperaldosteronism, and vomiting. Hypokalemic periodic paralysis typically strikes suddenly in the early morning or after a heavy meal or exercise, presenting with hypokalemia plus hypophosphatemia plus normal urine potassium; TPP occurs in young Asian men with hyperthyroidism, with a urine Ca-to-P ratio above 1.6 — reverse that direction and the answer is wrong. Bartter syndrome is a thick-ascending-limb mutation resembling furosemide, with hypokalemia plus alkalosis plus normal blood pressure; Gitelman syndrome is an NCC defect in the distal convoluted tubule resembling thiazide, plus hypomagnesemia and hypocalciuria. Mild cases take oral potassium; only severe cases go intravenous. The ECG progression of hyperkalemia is likewise a chain: rising potassium makes the resting membrane shallower and slows repolarization, so the T wave becomes tall and peaked first, then the PR interval prolongs, the P wave disappears, the QRS widens, then a sine wave appears, and finally fibrillation or arrest. The pathway by which NSAIDs cause hyperkalemia is inhibiting prostaglandins to constrict the renal vessels, reducing distal potassium secretion, and suppressing renin secretion. Emergency treatment starts with calcium gluconate to stabilize the myocardial membrane, then insulin plus glucose, a β-agonist, and sodium bicarbonate to drive potassium into cells, and finally diuretics, potassium binders, and dialysis to remove potassium. Patiromer trades calcium for potassium, with a side effect of hypomagnesemia rather than hypermagnesemia. Calcium and phosphate metabolism: primary hyperparathyroidism is autonomous adenoma secretion, with high calcium plus low phosphate; secondary hyperparathyroidism in CKD arises because the kidney's failure to excrete phosphate causes high phosphate plus low active vitamin D plus low calcium, which stimulates parathyroid hormone, so PTH is high while calcium is low or normal; tertiary hyperparathyroidism is autonomous transformation, with calcium flipping high. The key to the differential is the direction of the serum phosphate: primary disease is high calcium plus low phosphate, secondary disease is low or normal calcium plus high phosphate. Hypocalcemia lowers the threshold and produces neuromuscular hyperexcitability, hence Chvostek's sign, Trousseau's sign, tetany, and QT prolongation; hypercalcemia is suppressive, hence weakness, constipation, and lethargy — never, ever reverse that direction.